Relmada Therapeutics, Inc. (RLMD)

3.84 -0.22 (-5.42%) USD  |  NASDAQ  |  Jan 14, 16:00
3.81 -0.03 (-0.78%) After-Hours: 06:23
More

Relmada Therapeutics Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for RLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Invivyd, Inc. Upgrade
Arcellx, Inc. Upgrade
Puma Biotechnology, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade